Cargando…
Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21
A universal biomarker panel with the potential to predict high-risk pregnancies or adverse pregnancy outcome does not exist. Transcriptome analysis is a powerful tool to capture differentially expressed genes (DEG), which can be used as biomarker-diagnostic-predictive tool for various conditions in...
Autores principales: | Volk, Marija, Maver, Aleš, Lovrečić, Luca, Juvan, Peter, Peterlin, Borut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774664/ https://www.ncbi.nlm.nih.gov/pubmed/24066117 http://dx.doi.org/10.1371/journal.pone.0074184 |
Ejemplares similares
-
Transcriptome Profiling Uncovers Potential Common Mechanisms in Fetal Trisomies 18 and 21
por: Volk, Marija, et al.
Publicado: (2017) -
Assessment of pathogenic variation in gynecologic cancer genes in a national cohort
por: Kotnik, Urška, et al.
Publicado: (2023) -
Clinical utility of array comparative genomic hybridisation in prenatal setting
por: Lovrecic, Luca, et al.
Publicado: (2016) -
Optical genome mapping in an atypical Pelizaeus-Merzbacher prenatal challenge
por: Rogac, Mihael, et al.
Publicado: (2023) -
An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)